Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher W Ajello

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208Roland E Dolle, Mathieu Michaut, Blanca Martinez-Teipel, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activityBertrand Le Bourdonnec, Christopher W Ajello, Pamela R Seida, et al.
The Open Medicinal Chemistry Journal|December 8, 2009
Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization InhibitorsGuo-Hua Chu, Bertrand Le Bourdonnec, Minghua Gu, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
CB2 selective sulfamoyl benzamides: optimization of the amide functionalityAllan J Goodman, Christopher W Ajello, Karin Worm, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stabilityIan Sellitto, Bertrand Le Bourdonnec, Karin Worm, et al.
Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|May 26, 2009
Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208Roland E Dolle, Mathieu Michaut, Blanca Martinez-Teipel, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activityBertrand Le Bourdonnec, Christopher W Ajello, Pamela R Seida, et al.
The Open Medicinal Chemistry Journal|December 8, 2009
Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization InhibitorsGuo-Hua Chu, Bertrand Le Bourdonnec, Minghua Gu, et al.
Bioorganic & Medicinal Chemistry Letters|December 19, 2008
CB2 selective sulfamoyl benzamides: optimization of the amide functionalityAllan J Goodman, Christopher W Ajello, Karin Worm, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stabilityIan Sellitto, Bertrand Le Bourdonnec, Karin Worm, et al.
Journal of Medicinal Chemistry|September 16, 2008
Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4'-piperidine]-4-yl)benzamide (ADL5859)Bertrand Le Bourdonnec, Rolf T Windh, Christopher W Ajello, et al.
Journal of Medicinal Chemistry|August 22, 2009
Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4'-piperidine]-4-yl) benzamide (ADL5747)Bertrand Le Bourdonnec, Rolf T Windh, Lara K Leister, et al.
Pageof 1